AU2003258922A1 - PYRAZOLO (4,3c) CINNOLINE COMPOUNDS AS INHIBITORS OF ITK KINASE ACTIVITY - Google Patents

PYRAZOLO (4,3c) CINNOLINE COMPOUNDS AS INHIBITORS OF ITK KINASE ACTIVITY

Info

Publication number
AU2003258922A1
AU2003258922A1 AU2003258922A AU2003258922A AU2003258922A1 AU 2003258922 A1 AU2003258922 A1 AU 2003258922A1 AU 2003258922 A AU2003258922 A AU 2003258922A AU 2003258922 A AU2003258922 A AU 2003258922A AU 2003258922 A1 AU2003258922 A1 AU 2003258922A1
Authority
AU
Australia
Prior art keywords
pyrazolo
inhibitors
kinase activity
itk kinase
cinnoline compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003258922A
Inventor
Jan Dahmen
Martin Hemmerling
Tomas Klingstedt
Peter Sjo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2003258922A1 publication Critical patent/AU2003258922A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003258922A 2002-08-14 2003-08-13 PYRAZOLO (4,3c) CINNOLINE COMPOUNDS AS INHIBITORS OF ITK KINASE ACTIVITY Abandoned AU2003258922A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0202461A SE0202461D0 (en) 2002-08-14 2002-08-14 Novel compounds
SE0202461-0 2002-08-14
PCT/SE2003/001278 WO2004016615A1 (en) 2002-08-14 2003-08-13 PYRAZOLO (4,3c) CINNOLINE COMPOUNDS AS INHIBITORS OF ITK KINASE ACTIVITY

Publications (1)

Publication Number Publication Date
AU2003258922A1 true AU2003258922A1 (en) 2004-03-03

Family

ID=20288749

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003258922A Abandoned AU2003258922A1 (en) 2002-08-14 2003-08-13 PYRAZOLO (4,3c) CINNOLINE COMPOUNDS AS INHIBITORS OF ITK KINASE ACTIVITY

Country Status (3)

Country Link
AU (1) AU2003258922A1 (en)
SE (1) SE0202461D0 (en)
WO (1) WO2004016615A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7465795B2 (en) 2005-12-20 2008-12-16 Astrazeneca Ab Compounds and uses thereof
WO2007073283A1 (en) * 2005-12-20 2007-06-28 Astrazeneca Ab Substituted cinnoline derivatives as gabaa-receptor modulators and method for their synthesis
WO2007126913A1 (en) * 2006-03-27 2007-11-08 The Government Of The U.S.A. As Represented By The Secretary Department Of Health & Human Services Methods for prevention or treatment of viral disease
WO2013153539A1 (en) 2012-04-13 2013-10-17 Glenmark Pharmaceuticals S.A. Tricyclic compounds as tec kinase inhibitors
CA2928721C (en) 2013-10-25 2020-12-22 Pharmacyclics Llc Use of ibrutinib for treating and preventing chronic graft versus host disease
MA45973A (en) 2015-08-31 2019-06-26 Pharmacyclics Llc BTK INHIBITOR COMBINATIONS FOR THE TREATMENT OF MULTIPLE MYELOMA
CN110139669A (en) 2016-11-03 2019-08-16 朱诺治疗学股份有限公司 The combination treatment of T cell therapy and BTK inhibitor
PE20200608A1 (en) 2017-06-30 2020-03-10 Bayer Animal Health Gmbh NEW DERIVATIVES OF AZAQUINOLINE
JP7410877B2 (en) 2018-05-03 2024-01-10 ジュノー セラピューティクス インコーポレイテッド Combination therapy of chimeric antigen receptor (CAR) T cell therapy and kinase inhibitors
WO2023220655A1 (en) 2022-05-11 2023-11-16 Celgene Corporation Methods to overcome drug resistance by re-sensitizing cancer cells to treatment with a prior therapy via treatment with a t cell therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549833B1 (en) * 1983-07-26 1985-11-08 Roussel Uclaf PYRAZOLO / 4,3-C / CINNOLIN-3-ONE DERIVATIVES, SALTS THEREOF, PROCESS FOR PREPARATION, APPLICATION AS MEDICAMENTS, COMPOSITIONS CONTAINING THEM AND INTERMEDIATES
JPS61112075A (en) * 1984-11-05 1986-05-30 Shionogi & Co Ltd Thienylpyrazoloquinoline derivative
US4591589A (en) * 1985-01-16 1986-05-27 Roussel Uclaf 2-aryl pyrazolo[4,3-c]cinnolin-3-ones

Also Published As

Publication number Publication date
SE0202461D0 (en) 2002-08-14
WO2004016615A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
AU2002357773A1 (en) 1,6 naphthyridines useful as inhibitors of syk kinase
AU2003271566A1 (en) Pyrrolopyrazines as kinase inhibitors
EP1436290B8 (en) Alkyne-aryl-naphthyridin-4(1h)-0ne derivatives as type iv phosphodiesterase inhibitor
AU2003265349A1 (en) Pyrrolotriazine kinase inhibitors
EP1689393A4 (en) Preparation of 1,7-disubstituted azabenzimidazoles as kinase inhibitors
AU2003222055A1 (en) Kinase inhibitors
PL376844A1 (en) Methods for selectively inhibiting janus tyrosine kinase 3 (jak3)
AU2003286711A1 (en) Indazolinone compositions useful as kinase inhibitors
PT1690853E (en) Use of omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
AU2003275282A1 (en) Novel tyrosine kinase inhibitors
AU2002361577A1 (en) Tyrosine kinase inhibitors
AU2003237446A1 (en) Pyrazole-derivatives as p38 kinase inhibitors
AU2003254051A1 (en) Pyrazolopyrimidines as kinase inhibitors
AU2002348394A1 (en) Tyrosine kinase inhibitors
AU2003261204A1 (en) Pyrazolopyrimidines as kinase inhibitors
AU2003258922A1 (en) PYRAZOLO (4,3c) CINNOLINE COMPOUNDS AS INHIBITORS OF ITK KINASE ACTIVITY
AU2002348393A1 (en) Tyrosine kinase inhibitors
AU2002323406A1 (en) Tyrosine kinase inhibitors
AU2003249535A1 (en) 1,6-fused uracil derivatives as matrix metalloproteinase inhibitors
AU2003215635A1 (en) Thiazol-2-yl-imine compounds as pde-7 inhibitors
AU2003250465A1 (en) 5,6-fused uracil derivatives as matrix metalloproteinase inhibitors
AU2002253350A1 (en) 4-aminosulfonylquinazolines and -quinolines as tyrosine kinase inhibitors
AUPS251402A0 (en) Kinase inhibitors
AU2003293886A1 (en) (1,7)naphthyridines as pde4 inhibitors
AU2003300551A8 (en) Compounds for the inhibition of non-proteolytic enzymes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase